Injective Rallies Toward $9 as CEO Meets US Policymakers on Tokenization
- —INJ trades at $8.71, above 50-day EMA of $6.94 and 200-day EMA of $5.76
- —CEO Eric Chen met with White House, SEC and CFTC officials on Wednesday
- —Exchange-held INJ dropped from 1.26 million to 872,500 tokens
- —77.01% of circulating supply is in profit, up from 41.16%
Why it matters: The meeting with US regulators strengthens Injective's position in RWA tokenization and could accelerate institutional adoption.
Source: FXStreet Crypto